MCC in cells of patients with chALL1 revealed direct interactions between the putative enhancers and the promoters of MEIS1, RUNX2, and CD69 (Figure 6A-D; supplemental Figure 6C). This evidence concerns the gene RUNX2 and Merkel cell skin cancer.